Key result
Volumetric RV-PA coupling indices improve risk discrimination over conventional RVEF for death or HF hospitalization.
Why the study?
Accurate assessment of right ventricular performance in severe tricuspid regurgitation is challenging because conventional RVEF may overestimate function by not accounting for regurgitant volume.
Do CMR-derived Vol RV-PA Coupling Index and effective RVEF improve prognostic risk discrimination compared to conventional RVEF in patients with severe tricuspid regurgitation?
Cohort (n=289)
Yes
Do CMR-derived Vol RV-PA Coupling Index and effective RVEF improve prognostic risk discrimination compared to conventional RVEF in patients with severe tricuspid regurgitation?
Effect estimate: Δ Harrell's C-index 0.056 and 0.043
p-value: p=<0.01
Novel CMR-derived volumetric indices (Vol RV-PA Coupling Index and effective RVEF) offer superior prognostic risk stratification over conventional RVEF in patients with severe tricuspid regurgitation.
May refine risk stratification in severe TR; leaves open prospective validation before clinical adoption.
BACKGROUND Accurate assessment of right ventricular (RV) performance is crucial in patients with severe tricuspid regurgitation (TR). Conventional RV ejection fraction (RVEF) may overestimate RV systolic function because it does not account for regurgitant volume in severe TR. This study aimed to evaluate the prognostic value of two novel CMR-derived indices of RV function-a volumetric surrogate of RV-pulmonary artery (PA) coupling (Vol RV-PA Coupling Index) and effective RV ejection fraction (effective RVEF), which accounts for regurgitant volume-compared with conventional RVEF. METHODS In this multicentre study, 289 patients with severe TR (mean age 71 ± 11 years, 66% women) underwent comprehensive CMR assessment and long-term follow-up. The primary endpoint was the first occurrence of all-cause death or heart failure hospitalisation. A pre-specified secondary analysis evaluated an expanded composite endpoint including all-cause death, heart failure hospitalisation, or tricuspid valve intervention (TVI). A subgroup of 50 patients underwent repeat CMR after TVI. RESULTS During follow-up, 106 patients (37%) reached the primary endpoint. Both the Vol RV-PA Coupling Index and effective RVEF were independently associated with the primary endpoint and significantly improved risk discrimination beyond conventional RVEF (Δ Harrell's C-index 0.056 and 0.043, respectively; both p < 0.01). Similar findings were observed for the expanded composite endpoint. Following TVI, both indices improved significantly and were associated with mortality during post-intervention follow-up. CONCLUSIONS Vol RV-PA Coupling Index and effective RVEF are complementary CMR-derived markers of RV performance that provide incremental prognostic information beyond conventional RVEF in patients with severe TR. Their improvement after TVI further supports their potential role for longitudinal assessment of RV performance.
No takes yet. Share an insight, caveat, or question.
Its licence doesn't allow us to show a copy here.
Hinojar et al. (2026) conducted a cohort in severe tricuspid regurgitation (n=289). Vol RV-PA Coupling Index and effective RVEF vs. conventional RVEF was evaluated on first occurrence of all-cause death or heart failure hospitalisation (Δ Harrell's C-index 0.056 and 0.043, p=<0.01). The Vol RV-PA Coupling Index and effective RVEF improved risk discrimination for death or heart failure hospitalization compared to conventional RVEF (Δ C-index 0.056 and 0.043; p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: